The maker of OxyContin is seeking Food and Drug Administration approval to label the controversial painkiller for use by children as young as 6 in a move that could serve to extend the company’s expiring patent on the lucrative drug.

Purdue Pharma has paid dozens of clinical sites around the country to document what happens when OxyContin, an addictive pharmaceutical widely abused by recreational users, is given to children. The family-owned pharmaceutical company earned an estimated $2.8 billion in revenue last year from sales of the powerful opioid, part of the same drug family as morphine and heroin.

2 Responses

With your kids paying big money to play aggressive sports is yet just another justification for this, as to why & how our kids are encouraged to play just aggressive sports and no other activities. Pharma has been waiting for this planned activity & now they got their wish, to drug up those with many injuries. Sick bastards!